We have located links that may give you full text access.
Recent Developments in the Epidemiology, Diagnosis, Treatment, and Prevention of Neurocysticercosis.
Current Infectious Disease Reports 1999 December
Neuroimaging studies have revealed that neurocysticercosis is a major cause of neurologic disease in most developing countries and is an emerging disease in industrialized areas. Patients with neurocysticercosis present mainly with seizures (parenchymal form) or intracranial hypertension (ventricular/subarachnoid forms). Management should be based on a thorough understanding of the pathogenesis and natural history of infection. Symptoms of active parenchymal neurocysticercosis result from the host inflammatory response to the dying metacestode form. Careful use of anticonvulsants will result in an excellent clinical outcome. The anthelminthic drugs albendazole and praziquantel are effective in killing the cysts, but their long-term effect on prognosis is unproven. Patients with obstructive hydrocephalus from ventricular cysts should be managed surgically by cerebrospinal fluid diversion or cyst removal. Treatment with antiparasitic drugs (especially albendazole) and corticosteroids may decrease the incidence of shunt failure. Current efforts at control of the disease include mass human or porcine chemotherapy in endemic zones and vaccination.
Full text links
Related Resources
Trending Papers
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app